Search filters

List of works by Jikui Guan

A heat-shock protein 40, DNAJB13, is an axoneme-associated component in mouse spermatozoa

scientific journal article

ALKALs are in vivo ligands for ALK family receptor tyrosine kinases in the neural crest and derived cells

scientific article published on 9 January 2018

Anaplastic lymphoma kinase L1198F and G1201E mutations identified in anaplastic thyroid cancer patients are not ligand-independent.

scientific article published on 24 December 2016

Brigatinib, an anaplastic lymphoma kinase inhibitor, abrogates activity and growth in ALK-positive neuroblastoma cells, Drosophila and mice

scientific article

Clinical response of the novel activating ALK-I1171T mutation in neuroblastoma to the ALK inhibitor ceritinib

scientific article published on 01 August 2018

DNAJB13 is a radial spoke protein of mouse '9+2' axoneme.

scientific article published in December 2010

Extracellular domain shedding of the ALK receptor mediates neuroblastoma cell migration

scientific article published on 01 July 2021

FAM150A and FAM150B are activating ligands for anaplastic lymphoma kinase

scientific journal article

Gene expression profiles in different stages of mouse spermatogenic cells during spermatogenesis

scientific article published on 19 February 2003

MEK inhibitor trametinib does not prevent the growth of anaplastic lymphoma kinase (ALK)-addicted neuroblastomas

scientific article published on 28 November 2017

Novel Mechanisms of ALK Activation Revealed by Analysis of the Y1278S Neuroblastoma Mutation

scientific article published on 30 October 2017

Phosphoproteome and gene expression profiling of ALK inhibition in neuroblastoma cell lines reveals conserved oncogenic pathways

article

Spatiotemporal association of DNAJB13 with the annulus during mouse sperm flagellum development

scientific article

Stage-specific and tissue-specific expression characteristics of differentially expressed genes during mouse spermatogenesis

scientific article

The ALK inhibitor PF-06463922 is effective as a single agent in neuroblastoma driven by expression of ALK and MYCN

scientific article published on 07 July 2016